Patents by Inventor Ralf Zielenski

Ralf Zielenski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8927261
    Abstract: The invention concerns a method for isolating and purifying nucleic acids from a sample and a device that is suitable therefore.
    Type: Grant
    Filed: March 1, 2012
    Date of Patent: January 6, 2015
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Dirk Block, Ruediger Haenel, Joerg Kleiber, Manuela Poignee-Heger, Thomas Walter, Ralf Zielenski
  • Publication number: 20120152818
    Abstract: The invention concerns a method for isolating and purifying nucleic acids from a sample and a device that is suitable therefore.
    Type: Application
    Filed: March 1, 2012
    Publication date: June 21, 2012
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Dirk Block, Ruediger Haenel, Joerg Kleiber, Manuela Poignee-Heger, Thomas Walter, Ralf Zielenski
  • Patent number: 8158349
    Abstract: The invention concerns a method for isolating and purifying nucleic acids from a sample and a device that is suitable therefore.
    Type: Grant
    Filed: January 14, 2011
    Date of Patent: April 17, 2012
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Dirk Block, Ruediger Haenel, Joerg Kleiber, Manuela Poignee-Heger, Thomas Walter, Ralf Zielenski
  • Publication number: 20110137020
    Abstract: The invention concerns a method for isolating and purifying nucleic acids from a sample and a device that is suitable therefore.
    Type: Application
    Filed: January 14, 2011
    Publication date: June 9, 2011
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Dirk Block, Ruediger Haenel, Joerg Kleiber, Manuela Poignee-Heger, Thomas Walter, Ralf Zielenski
  • Patent number: 7897378
    Abstract: The invention concerns a method for isolating and purifying nucleic acids from a sample and a device that is suitable therefore.
    Type: Grant
    Filed: February 7, 2005
    Date of Patent: March 1, 2011
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Dirk Block, Ruediger Haenel, Joerg Kleiber, Manuela Poignee-Heger, Thomas Walter, Ralf Zielenski
  • Patent number: 7491495
    Abstract: The present invention is directed to a method for adsorbing, i.e. non-covalently binding, nucleic acids to a solid phase using a two-step procedure. Furthermore, the present invention pertains to a method for isolating nucleic acids from a biological sample. In the first step of the procedure, lysis is effected by mixing the biological sample with an aqueous lysis buffer containing a chaotropic agent and incubating the mixture; in the second step, the concentration of the chaotropic agent in the mixture is increased and the mixture is contacted with the solid phase, whereby the nucleic acids in the liquid phase is adsorbed to the solid phase.
    Type: Grant
    Filed: February 18, 2005
    Date of Patent: February 17, 2009
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Ralf Zielenski, Klaus Geissler, Thomas Walter
  • Patent number: 7329491
    Abstract: A method for purification of a nucleic acid comprising the steps of (a) adsorbing on a substrate the nucleic acid from a composition containing (i) an aqueous buffer, (ii) salts in a high concentration, (iii) a water-miscible, non-acidic organic compound, and (iv) the nucleic acid; (b) optionally washing with a washing solution the substrate with the adsorbed nucleic acid; (c) contacting the substrate with the adsorbed nucleic acid with a solution containing salts in a lower concentration compared to the composition of step (a), thereby desorbing the nucleic acid from the substrate; (d) separating the solution with the desorbed nucleic acid from the substrate, thereby purifying the nucleic acid; and optionally (e) precipitating the desorbed nucleic acid from the solution of step (d) and isolating the precipitated nucleic acid, thereby further purifying the nucleic acid.
    Type: Grant
    Filed: October 12, 2004
    Date of Patent: February 12, 2008
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Michael Kirchgesser, Frank Bergmann, Thomas Walter, Kurt Weindel, Ralf Zielenski, Emad Sarofim
  • Patent number: 7300769
    Abstract: Stabilized aqueous solution of a coenzyme for hydrogen-transferring enzymes characterized in that the solution contains NAD, NADP or a derivative thereof in an oxidized or reduced form and one or several organic compounds or salts thereof having a pKa value between 1.5 and 6.0 and/or a nitrogen compound of the general formula in which the residues R1, R2 and R3 are the same or different and denote hydrogen, or a saturated or unsaturated alkyl or aryl group as well as the use of the solution to determine dehydrogenases in particular lactate dehydrogenase or substrates thereof.
    Type: Grant
    Filed: February 11, 2005
    Date of Patent: November 27, 2007
    Assignee: Roche Diagnostics Operations, Inc.
    Inventor: Ralf Zielenski
  • Publication number: 20050214926
    Abstract: The present invention is directed to a method for adsorbing, i.e. non-covalently binding, nucleic acids to a solid phase using a two-step procedure. Furthermore, the present invention pertains to a method for isolating nucleic acids from a biological sample. In the first step of the procedure, lysis is effected by mixing the biological sample with an aequous lysis buffer containing a chaotropic agent and incubating the mixture; in the second step, the concentration of the chaotropic agent in the mixture is increased and the mixture is contacted with the solid phase, whereby the nucleic acids in the liquid phase is adsorbed to the solid phase.
    Type: Application
    Filed: February 18, 2005
    Publication date: September 29, 2005
    Inventors: Ralf Zielenski, Klaus Geissler, Thomas Walter
  • Publication number: 20050208548
    Abstract: The invention concerns a method for isolating and purifying nucleic acids from a sample and a device that is suitable therefore.
    Type: Application
    Filed: February 7, 2005
    Publication date: September 22, 2005
    Applicant: ROCHE MOLECULAR SYSTEMS, INC
    Inventors: Dirk Block, Ruediger Haenel, Joerg Kleiber, Manuela Poignee-Heger, Thomas Walter, Ralf Zielenski
  • Publication number: 20050202487
    Abstract: The present invention is directed to methods and kits for isolation of bacteria from biological samples. In such methods antibodies specific for eukaryotic cells, which are deficient in a bacteria-binding Fc-terminus, are used for separating eukaryotic cells from biological samples.
    Type: Application
    Filed: March 1, 2005
    Publication date: September 15, 2005
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Juergen Klepp, Peter Kaspar, Ralf Zielenski, Reiner Schlipfenbacher
  • Publication number: 20050136505
    Abstract: Stabilized aqueous solution of a coenzyme for hydrogen-transferring enzymes characterized in that the solution contains NAD, NADP or a derivative thereof in an oxidized or reduced form and one or several organic compounds or salts thereof having a pKa value between 1.5 and 6.0 and/or a nitrogen compound of the general formula in which the residues R1, R2 and R3 are the same or different and denote hydrogen, or a saturated or unsaturated alkyl or aryl group as well as the use of the solution to determine dehydrogenases in particular lactate dehydrogenase or substrates thereof.
    Type: Application
    Filed: February 11, 2005
    Publication date: June 23, 2005
    Inventor: Ralf Zielenski
  • Publication number: 20050079535
    Abstract: A method for purification of a nucleic acid comprising the steps of (a) adsorbing on a substrate the nucleic acid from a composition containing (i) an aqueous buffer, (ii) salts in a high concentration, (iii) a water-miscible, non-acidic organic compound, and (iv) the nucleic acid; ( b) optionally washing with a washing solution the substrate with the adsorbed nucleic acid; (c) contacting the substrate with the adsorbed nucleic acid with a solution containing salts in a lower concentration compared to the composition of step (a), thereby desorbing the nucleic acid from the substrate; (d) separating the solution with the desorbed nucleic acid from the substrate, thereby purifying the nucleic acid; and optionally (e) precipitating the desorbed nucleic acid from the solution of step (d) and isolating the precipitated nucleic acid, thereby further purifying the nucleic acid.
    Type: Application
    Filed: October 12, 2004
    Publication date: April 14, 2005
    Inventors: Michael Kirchgesser, Frank Bergmann, Thomas Walter, Kurt Weindel, Ralf Zielenski, Emad Sarofim
  • Patent number: 6322993
    Abstract: The invention concerns a method and reagent for the determination of lipase in the presence of a colour substrate and at least one N-substituted carboxylic acid amide derivative or a compound of the general formula (I) or (Ia) in which R1 and R2 independently of one another represent hydrogen or a saturated or unsaturated, substituted or unsubstituted hydrocarbon residue with 2 to 24 carbon atoms, Z denotes a saturated or unsaturated, substituted, cyclic or straight-chained hydrocarbon residue with 1 to 10 carbon atoms, X represents an atom or a group of atoms with positive charge and n is a number from 1 to 3. Tetra-sodium-N-(1,2-dicarboxylethyl)-N-alkylsulfosuccinamide or a mixture containing such a compound has proven to be particularly advantageous for the elimination of unspecific reactions in the determination of lipase in a biological sample.
    Type: Grant
    Filed: May 8, 1998
    Date of Patent: November 27, 2001
    Assignee: Roche Diagnostics GmbH
    Inventors: Lieselotte Schelong, Ralf Zielenski, Urban Prinzing
  • Publication number: 20010044128
    Abstract: Stabilized aqueous solution of a coenzyme for hydrogen-transferring enzymes characterized in that the solution contains NAD, NADP or a derivative thereof in an oxidized or reduced form and one or several organic compounds or salts thereof having a pKa value between 1.5 and 6.
    Type: Application
    Filed: January 12, 2001
    Publication date: November 22, 2001
    Inventor: Ralf Zielenski
  • Patent number: 6162615
    Abstract: Stabilized aqueous coenzyme solutions which contain up to ca. 60 mM of a heavy metal salt and optionally a complexing agent in a defined ratio to the heavy metal salt as well as their use for the determination of dehydrogenases in particular lactate dehydrogenase or corresponding substrates in an alkaline environment.
    Type: Grant
    Filed: October 16, 1997
    Date of Patent: December 19, 2000
    Assignee: Roche Diagnostics GmbH
    Inventor: Ralf Zielenski